Massivemarkets

SEC Form 4

Aktis Oncology, Inc. (AKTS) insider trading

In the 12 months to Nov 19, 2026, 3 AKTS insiders reported open-market sales of $3.2M across 5 filings; 6 insiders bought $114.3M.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$3.2M
5 filings · 3 insiders
Open-market purchases
$114.3M
6 filings
Pre-arranged sales (10b5-1)
1 of 5
$258.6K of $3.2M sold (8%)

Who traded AKTS, and when

  • Purchase
  • Sale
  • Sale, pre-arranged (10b5-1)

AKTS daily close from Jan 9, 2026 to Nov 18, 2026, between $14.59 and $32.23, last $16.10. 5 sale and 6 purchase filings by 9 insiders, marked at their filing dates. Oleg Nodelman, Director: bought $40.0M across 1 filing, first filed Jan 12, 2026, last Jan 12, 2026. Ansbert Gadicke, 10% owner: bought $20.0M across 1 filing, first filed Jan 14, 2026, last Jan 14, 2026. Luke Evnin, 10% owner: bought $20.0M across 1 filing, first filed Jan 14, 2026, last Jan 14, 2026. Helen Susan Kim, Director: bought $15.0M across 1 filing, first filed Jan 12, 2026, last Jan 12, 2026. VIDA VENTURES II-A, LLC, 10% owner: bought $15.0M across 1 filing, first filed Jan 12, 2026, last Jan 12, 2026. Todd Foley, Director: bought $4.2M across 1 filing, first filed Jan 14, 2026, last Jan 14, 2026. 3 others: sold $3.2M across 5 filings, first filed Jul 10, 2026, last Sep 24, 2026.

Largest mark · tap a row for others

Oleg Nodelman · Director

Purchase $39,999,996

2,222,222 shares at $18.00 avg

Filed Jan 12, 2026

Close on filing date $21.75

AKTS daily closelast $16.10

Oleg Nodelman · Director

$40.0M bought

Ansbert Gadicke · 10% owner

$20.0M bought

Luke Evnin · 10% owner

$20.0M bought

Helen Susan Kim · Director

$15.0M bought

VIDA VENTURES II-A, LLC · 10% owner

$15.0M bought

Todd Foley · Director

$4.2M bought

3 others

$3.2M sold
One row per insider, smaller filers combined; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

11 filings in the last 12 months
Other insider activity (not market trades) · 23 records
  • Option exercises6 records
  • Other17 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Counted once
When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

Frequently asked questions

How current is AKTS’s insider data?

These are AKTS Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track AKTS insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for AKTS every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.